-
Product Insights
New![]()
Ras Al-Khair IWPP – GT
Ras Al-Khair IWPP - GT is a thermal project located in Eastern Province, Saudi Arabia. The project is owned by Saline Water Conversion Corp and was developed by Saline Water Conversion Corp; Saudi Electricity Co. The project is currently active. Empower your strategies with our Ras Al-Khair IWPP - GT report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
New![]()
ExxonMobil Beaumont Refinery GT Cogeneration Plant
ExxonMobil Beaumont Refinery GT Cogeneration Plant is a thermal project located in Texas, United States. The project is owned by Exxon Mobil Corp. The project came online in 1993. Empower your strategies with our ExxonMobil Beaumont Refinery GT Cogeneration Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
New![]()
Chalk Point Power Plant (GT 3-6)
Chalk Point Power Plant (GT 3-6) is a thermal project located in Maryland, United States. The project is owned by GenOn Holdings Inc. The project came online in 1991. Empower your strategies with our Chalk Point Power Plant (GT 3-6) report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GT-002 in Schizophrenia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GT-002 in Schizophrenia Drug Details: GT-002 is under development for the treatment of psychosis, depression,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GT-20029 in Acne Vulgaris
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.GT-20029 in Acne Vulgaris Drug Details:GT-20029 is under development for the treatment of androgenetic alopecia and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GT-0002X in Parkinson’s Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.GT-0002X in Parkinson's Disease Drug Details:Gene therapy is under development for the treatment of Parkinson's disease...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GT-20029 in Androgenic Alopecia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.GT-20029 in Androgenic AlopeciaDrug Details:GT-20029 is under development for the treatment of androgenetic alopecia and acne...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GT-0002X in Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.GT-0002X in Aromatic l-Amino Acid Decarboxylase (AADC) DeficiencyDrug Details:Gene therapy is under development for the treatment...
-
Sector Analysis
New![]()
Automotive Heavy Trucks Market Trends and Analysis by Technology, Companies and Forecast to 2028
Automotive Heavy Trucks Market Overview The automotive heavy trucks market is valued at 3.1 million units in 2023 and is expected to record a CAGR of more than 3% during 2023-2028. Due to new product introductions, partnerships between engine manufacturers and mining equipment OEMs, and capacity growth by the top OEMs, the market for electric heavy-duty trucks is anticipated to grow. A big push for the adoption of electric heavy-duty trucks worldwide is also being provided by significant contracts between...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GNOSPV-02 in Metastatic Hepatocellular Carcinoma (HCC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.GNOSPV-02 in Metastatic Hepatocellular Carcinoma (HCC) Drug Details:GNOSPV-02 is under development for the treatment of metatstic...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.